A large orthopaedic group across the Kansas City metropolitan area whose regenerative service offers bone marrow concentrate and platelet injections for joint and tendon problems.
Kansas City Orthopedic Alliance is a substantial orthopaedic group practice working across the Kansas City metropolitan area on both sides of the state line. The site lists six offices: Overland Park, Leawood, Shawnee Mission and Lenexa in Kansas, and Belton and Blue Springs in Missouri. Regenerative injection treatment sits inside a full orthopaedic service rather than being the whole of what the practice does, which gives a patient the option of being assessed by surgeons who also offer conventional treatment.
The two regenerative treatments described are bone marrow concentrate (BMC), prepared from the patient's own bone marrow, and platelet rich plasma (PRP, prepared from the patient's own blood). Both are autologous, meaning the material comes from the patient's own body; no donor-derived or amniotic products are named on the pages reviewed.
The site is unusually informative about technique, which is worth noting. It argues that how bone marrow is drawn matters a great deal, citing published work to the effect that two doctors taking the same volume from the same person can obtain very different numbers of cells, and that drawing small volumes from several sites within the marrow yields more cells than a single large draw. It says Dr Khadavi has been teaching other physicians these techniques since 2014. This is a statement about cell yield rather than about patient benefit, and should not be read as evidence that the treatment works.
The site also distinguishes which treatment it considers suited to which problem, and gives expected durations of relief — roughly six to twelve months for platelet rich plasma in mild to moderate osteoarthritis, and two to four years for bone marrow concentrate. Those are the practice's own estimates, reported here rather than endorsed, and the site offers no outcome data to support them. No prices are published and no insurance statement is made, which matters particularly here because the group's conventional orthopaedic work would ordinarily be insured while the injections generally are not.
The site sets out which conditions it considers suited to platelet treatment and which to bone marrow concentrate, which is more specific than most clinics manage.
The site says its cell treatment is bone marrow concentrate taken from the patient's own marrow, and places considerable weight on how carefully the marrow is drawn.
The group is large; the pages reviewed identify the regenerative work chiefly with one physician.
The practice works from six outpatient offices across the Kansas City metropolitan area, spanning both Kansas and Missouri, and forms part of a full orthopaedic service rather than a standalone injection clinic. The pages reviewed describe ultrasound-guided injection but do not detail imaging equipment, cell processing laboratories or accreditation, and do not say at which of the six sites regenerative procedures are carried out.
No prices are published and the pages reviewed make no statement about insurance. As the group combines conventional orthopaedic care, which United States insurers generally cover, with regenerative injections, which they generally do not, a prospective patient should ask for a written breakdown of what would be billed to insurance and what would be self-funded.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.